Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Total Non-Current Liabilities: 2020-2024

Historic Total Non-Current Liabilities for Agilon Health (AGL) over the last 5 years, with FY2024 value amounting to $1.2 billion.

  • Agilon Health's Total Non-Current Liabilities fell 1413.81% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1413.81%. This contributed to the annual value of $1.2 billion for FY2024, which is 1757.82% up from last year.
  • As of FY2024, Agilon Health's Total Non-Current Liabilities stood at $1.2 billion, which was up 1757.82% from $1.0 billion recorded in FY2023.
  • In the past 5 years, Agilon Health's Total Non-Current Liabilities ranged from a high of $1.2 billion in FY2024 and a low of $331.5 million during FY2020
  • Its 5-year average for Total Non-Current Liabilities is $700.5 million, with a median of $574.4 million in 2022.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 7575.24% in 2023, then skyrocketed by 1757.82% in 2024.
  • Over the past 5 years, Agilon Health's Total Non-Current Liabilities (Annual) stood at $331.5 million in 2020, then grew by 20.77% to $400.4 million in 2021, then surged by 43.46% to $574.4 million in 2022, then soared by 75.75% to $1.0 billion in 2023, then grew by 17.58% to $1.2 billion in 2024.
  • Its Total Non-Current Liabilities was $1.2 billion in FY2024, compared to $1.0 billion in FY2023 and $574.4 million in FY2022.